Take the First Step: (770) 817-0711

Drugs

CVS Joins the Fight Against Prescription Drug Abuse

pillsDrugstore chain CVS has joined the fight against prescription drug abuse. As reported by NBC News, CVS has announced that it has and will revoke dispensing privileges for physicians and other healthcare providers who write too many prescriptions for painkillers (including, hydrocodone, oxycodone, alprazolam, methadone and carisoprodol). So far, they have revoked the privilege of 26 physicians and healthcare providers.

In an attempt to crack down on prescription drug abuse, and in lieu of the Drug Enforcement Administration revoking the license of two CVS pharmacies in Florida after they were accused of dispensing excessive amounts of oxycodone in 2012, CVS began monitoring who was prescribing how much of certain painkillers. Read more

With Just One Use, Cocaine Can Rewire The Brain

In an alarming new study, researchers found that cocaine may rewire the brain and significantly alter decision-making after just one use.

Time-lapse images show wiring changes (the growth and loss of spines) in the brain cells of a live mouse over multiple days.

In an alarming new study, researchers found that cocaine may rewire the brain and significantly alter decision-making after just one use. The study, performed by UC Berkley and UC San Francisco’s Ernest Gallo Clinic and Research Center, found that “cocaine can speedily rewire high-level brain circuits that support learning, memory and decision-making.” The study also revealed new insight into the role of the brain’s frontal lobe when it comes to drug-seeking behavior. This discovery is important in understanding addiction and its treatment options. Read more

Molly: Is The ‘It’ Drug Really As Safe As People Say?

He says that like all street drugs, there is no way to know what the toxicity level of Molly is because it is unregulated, and its components (or what it is cut with) is inconsistent and often unknown. Is Molly, a drug thought to be pure MDMA, really as safe as people say it is, or is it just a dangerous lesson in rebranding? Many doctors are saying despite its reputation as a “pure” or “gentle” drug, there is no safe way to do Molly. Read more

The Methadone and Suboxone Deception

Methadone and Suboxone are longer acting and can be more addicting than heroin.What is the Methadone and Suboxone deception? And who is fueling it? Many unsuspecting substance abusers are being led to believe that by switching from their opiate of choice to a daily intake of Methadone or Suboxone that they are then “clean” or “sober.” When in fact, they are just switching from one opiate to another. With the truth being, as Dr. Julia Aharonov said in a recent article, that Methadone and Suboxone are longer acting and just as (if not more) addicting than heroin. Read more

Dopamine and Marijuana: Does the Stoner Stereotype Now Have Scientific Backing?

Marijuana lowers dopamine in the brain and affects motivationNew research regarding dopamine and marijuana gives scientific backing to the stoner stereotype of lackadaisical or slacker pot smokers. A recent study found that people who smoke marijuana regularly over a long period of time are more likely to produce less of the brain chemical that is linked to motivation: dopamine.

Using PET scans, U.K. researchers compared the brains of regular pot smokers to non-smokers of the same age and sex. The regular pot smokers in the study reported using marijuana quite heavily, began using the drug between the ages of 12 and 18, and had experienced symptoms of psychosis (bizarre thoughts or strange sensations) while using marijuana. What the researchers found was that the regular pot smokers, and those who began smoking pot at an early age, had lower levels of dopamine in a part of the brain known as the striatum. Read more

Should the FDA Approve Super Painkiller Zohydro ER?

Experts warn that painkiller Zohydro ER has a strong potential for misuse and dependenceThere is a new super painkiller called Zohydro ER that is waiting approval from the Food and Drug Administration (FDA). The new drug is causing a stir of controversy because of its strength and potential for misuse. Because of this, the new drug is being compared to other opiate painkillers such as Vicodin and OxyContin that have had devastating effects in regards to substance dependence.

Zohydro ER is an extended release (12 hour) form of the opiate drug called hydrocodone. Unlike other opiate painkillers on the market like Vicodin that are a mix of hydrocodone and acetaminophen, Zohydro ER contains 100 percent hydrocodone. Mixed opiate painkillers like Vicodin are extremely addictive, but a pure hydrocodone painkiller like Zohydro ER has an even greater potential for dependence.

Another painkiller, OxyContin, which is made from the opiate oxycodone, is the most abused prescription drug in the U.S. (Vicodin is second and Zohydro ER contains 10 times more hydrocodone than Vicodin). OxyContin was also a time-release drug in which crushing the pill avoided this function. This resulted in a major abuse problem and gave OxyContin (which is no longer available in its original form because of the rampant abuse) the label “hillbilly heroin.”

A major concern with Zohydro ER is its time-release strength, which is 12 hours (as opposed to Vicodin which is only 2-4 hours). As with OxyContin, abusers could potentially have access to the full strength of the pill by crushing it then eating or snorting it and receiving a large and dangerous dose of the opiate drug. Approval for this drug (the manufacturer, Zogenix, stands to make millions from it) comes at a time when prescription drug abuse and overdoses are reaching epidemic proportions in this country.

Page 3 of 712345...Last »

Receive Updates

Privacy Policy

All inquiries are held in the strictest confidence. Let us help you find the program that's right for you. Please call or email us TODAY!

No information on this site is intended to replace that of your physician or medical care provider.

Contact Information

ExecuCare
Advanced Recovery Center
1100 Poydras Street, Suite 2900
New Orleans, LA 70163
Main: 770.817.0711
Fax: 770.817.0640